EBR:BCART - Euronext Brussels - BE0974281132 - Common Stock - Currency: EUR
EBR:BCART (9/22/2023, 7:00:00 PM)
0.29
+0.01 (+1.75%)
The current stock price of BCART.BR is 0.29 EUR. In the past month the price decreased by -11.31%. In the past year, price decreased by -70.47%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 26.71 | 195.04B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 66.6 | 160.59B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.39 | 131.64B | ||
2M6.DE | MEDTRONIC PLC | 15.67 | 94.46B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.82 | 52.84B | ||
BOX.DE | BECTON DICKINSON AND CO | 14.59 | 51.31B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 29.08 | 39.15B | ||
DC4.DE | DEXCOM INC | 43.32 | 24.63B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 15.88 | 20.74B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 15.87 | 20.74B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 15.22 | 19.89B | ||
BIM.PA | BIOMERIEUX | 29.92 | 13.67B |
Biocartis Group NV engages in the development of personalized medicine for patients around the world. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 526 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
BIOCARTIS GROUP NV
Generaal de Wittelaan 11B
MALINES (MECHELEN) ANTWERPEN BE
Employees: 526
Company Website: https://biocartis.com/
Phone: 3215632600.0
The current stock price of BCART.BR is 0.29 EUR. The price increased by 1.75% in the last trading session.
The exchange symbol of BIOCARTIS GROUP NV is BCART and it is listed on the Euronext Brussels exchange.
BCART.BR stock is listed on the Euronext Brussels exchange.
9 analysts have analysed BCART.BR and the average price target is 1.12 EUR. This implies a price increase of 286.9% is expected in the next year compared to the current price of 0.29. Check the BIOCARTIS GROUP NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIOCARTIS GROUP NV (BCART.BR) has a market capitalization of 27.24M EUR. This makes BCART.BR a Nano Cap stock.
BIOCARTIS GROUP NV (BCART.BR) currently has 526 employees.
BIOCARTIS GROUP NV (BCART.BR) has a resistance level at 0.3. Check the full technical report for a detailed analysis of BCART.BR support and resistance levels.
The Revenue of BIOCARTIS GROUP NV (BCART.BR) is expected to grow by 3.76% in the next year. Check the estimates tab for more information on the BCART.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BCART.BR does not pay a dividend.
BIOCARTIS GROUP NV (BCART.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.1).
ChartMill assigns a fundamental rating of 2 / 10 to BCART.BR. BCART.BR may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months BCART.BR reported a non-GAAP Earnings per Share(EPS) of -1.1. The EPS decreased by -1.55% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 84% to BCART.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 36% and a revenue growth 3.76% for BCART.BR